Orbis Medicines is a Denmark-based startup founded in 2021 that operates in the Health and Wellness and Pharmaceutical industries. The company's focus lies in developing a groundbreaking platform aimed at revolutionizing drug discovery. This platform is designed to discover, develop, and deliver drug candidates for challenging targets.
In its latest funding round on 29 February 2024, Orbis Medicines secured an impressive €26.00M in a Seed Round investment. Notably, this funding was provided by renowned investors including Novo Holdings and Forbion.
With its forward-looking approach to drug discovery and strong investor support, Orbis Medicines holds substantial promise in addressing unmet medical needs and making a significant impact in the pharmaceutical space. The company's ambitious vision and strategic partnerships position it as a compelling prospect for potential investors seeking opportunities in the health and wellness sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | €26.00M | 2 |
|
29 Feb 2024 |
| Seed Round | Unknown | 1 |
|
01 Sep 2021 |
No recent news or press coverage available for Orbis Medicines.
We care about your data, and we'd love to use cookies make your experience better.
